Copyright
©The Author(s) 2023.
World J Transplant. Mar 18, 2023; 13(3): 86-95
Published online Mar 18, 2023. doi: 10.5500/wjt.v13.i3.86
Published online Mar 18, 2023. doi: 10.5500/wjt.v13.i3.86
Hyperacute rejection | Acute humoral xenograft rejection | Acute cellular xenograft rejection |
Time period | ||
Immediately after reperfusion of the graft (typically within 24 h) | Later after reperfusion (after 24 h) | After 3 d |
Immediate graft function | ||
No (no urine since reperfusion) | Yes, urine formation initially | Yes, urine formation initially |
Histopathologic features | ||
Massive hemorrhage; Immunoglobulin and fibrin deposition; Complement (C5b-9) deposition; Presence of neutrophils; Thrombosis, ± | Hemorrhage present; Immunoglobulin and fibrin deposition; Complement (C5b-9) deposition; Presence of neutrophils; Lymphocytes may be present; Necrosis and transmural infiltration by neutrophils in blood vessels can be present; Apoptosis may be present; Thrombosis present | No hemorrhage; Immunoglobulin and fibrin deposition, rare; Complement, ±; Presence of mononuclear (lymphoid) cells associated with tissue destruction (e.g., tubulitis); No thrombosis |
Type of vasculopathy | Histopathological features |
Chronic humoral rejection-associated vasculopathy | Arterial intimal thickening; Presence of TUNEL+ cells; Deposits of fibrin, immunoglobulins (IgG and IgM), and complement components (C3, C4d, and C5b-9) |
Chronic cellular rejection-associated vasculopathy | Mononuclear cell infiltration in the neointima; Active endothelialitis; TUNEL+ cells |
Combined chronic humoral and cellular rejection-associated vasculopathy | Fibrinoid material deposition and cellular infiltration in the arterial neointima with immunoglobulin and complement deposition and infiltration of T cells, macrophages, and polymorphonuclear leukocytes |
Fully developed vasculopathy | Narrowing of arteries with a fibrotic neointima, but without fibrinoid material, or cellular infiltration |
- Citation: Mubarak M. Transitioning of renal transplant pathology from allograft to xenograft and tissue engineering pathology: Are we prepared? World J Transplant 2023; 13(3): 86-95
- URL: https://www.wjgnet.com/2220-3230/full/v13/i3/86.htm
- DOI: https://dx.doi.org/10.5500/wjt.v13.i3.86